{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T15:57:46Z","timestamp":1793030266617,"version":"4.5.0"},"reference-count":30,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2018,11,20]],"date-time":"2018-11-20T00:00:00Z","timestamp":1542672000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Norske Kvinners Sanitetsforening (NO)"},{"name":"G. Unger Vetlesen Foundation (US)"},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 HL 112990-01"],"award-info":[{"award-number":["R01 HL 112990-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["5U01A1 113315-02"],"award-info":[{"award-number":["5U01A1 113315-02"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P01Hl108793-06"],"award-info":[{"award-number":["P01Hl108793-06"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0206545","type":"journal-article","created":{"date-parts":[[2018,11,20]],"date-time":"2018-11-20T18:27:10Z","timestamp":1542738430000},"page":"e0206545","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":40,"title":["Augmented concentrations of CX3CL1 are associated with interstitial lung disease in systemic sclerosis"],"prefix":"10.1371","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6467-7422","authenticated-orcid":true,"given":"Anna-Maria","family":"Hoffmann-Vold","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen Samuel","family":"Weigt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vyacheslav","family":"Palchevskiy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Volkmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajan","family":"Saggar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d8yvind","family":"Midtvedt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"May Brit","family":"Lund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torhild","family":"Garen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael C.","family":"Fishbein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abbas","family":"Ardehali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Ross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thor","family":"Ueland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e5l","family":"Aukrust","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph P.","family":"Lynch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert M.","family":"Elashoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d8yvind","family":"Molberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A.","family":"Belperio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2018,11,20]]},"reference":[{"key":"ref1","article-title":"EULAR Textbook on Rheumatic Diseases","author":"Y Allanore","year":"2012"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"272","DOI":"10.3389\/fimmu.2015.00272","article-title":"Pathogenesis of Systemic Sclerosis","volume":"6","author":"D Pattanaik","year":"2015","journal-title":"Front Immunol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/nrdp.2015.2","article-title":"Systemic sclerosis","volume":"1","author":"Y Allanore","year":"2015","journal-title":"Nat Rev Dis Primers"},{"issue":"2","key":"ref4","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.semarthrit.2014.05.010","article-title":"Mortality and survival in systemic sclerosis: systematic review and meta-analysis","volume":"44","author":"M Rubio-Rivas","year":"2014","journal-title":"Semin Arthritis Rheum"},{"issue":"10","key":"ref5","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1136\/ard.2009.114264","article-title":"Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database","volume":"69","author":"A Tyndall","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"ref6","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.3899\/jrheum.121390","article-title":"Survival and causes of death in an unselected and complete cohort of Norwegian patients with systemic sclerosis","volume":"40","author":"AM Hoffmann-Vold","year":"2013","journal-title":"J Rheumatol"},{"issue":"1","key":"ref7","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.semarthrit.2005.03.005","article-title":"Autoantibodies in systemic sclerosis","volume":"35","author":"VD Steen","year":"2005","journal-title":"Semin Arthritis Rheum"},{"issue":"2","key":"ref8","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1055\/s-0034-1371541","article-title":"Interstitial lung disease in systemic sclerosis","volume":"35","author":"AU Wells","year":"2014","journal-title":"Semin Respir Crit Care Med"},{"issue":"5","key":"ref9","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1056\/NEJMoa1114576","article-title":"Proteome-wide analysis and CXCL4 as a biomarker in systemic sclerosis","volume":"370","author":"L van Bon","year":"2014","journal-title":"The New England journal of medicine"},{"issue":"6617","key":"ref10","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1038\/385640a0","article-title":"A new class of membrane-bound chemokine with a CX3C motif","volume":"385","author":"J Bazan","year":"1997","journal-title":"Nature"},{"issue":"4","key":"ref11","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0092-8674(00)80438-9","article-title":"Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion","volume":"91","author":"T Imai","year":"1997","journal-title":"Cell"},{"issue":"4","key":"ref12","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1080\/17402520500303297","article-title":"Polymorphism of the fractalkine receptor CX3CR1 and systemic sclerosis-associated pulmonary arterial hypertension","volume":"12","author":"B Marasini","year":"2005","journal-title":"Clin Dev Immunol"},{"key":"ref13","first-page":"82","article-title":"Pathological role of fractalkine\/CX3CL1 in rheumatic diseases: a unique chemokine with multiple functions","volume":"2","author":"B Jones","year":"2011","journal-title":"Front Immunol"},{"issue":"8","key":"ref14","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1002\/art.39166","article-title":"Predictive value of serial high-resolution computed tomography analyses and concurrent lung function tests in systemic sclerosis","volume":"67","author":"AM Hoffmann-Vold","year":"2015","journal-title":"Arthritis Rheumatol"},{"issue":"2","key":"ref15","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.chest.2016.03.004","article-title":"High level of chemokine CCL18 is associated with pulmonary function deterioration, lung fibrosis progression and reduced survival in Systemic Sclerosis","volume":"150","author":"A Hoffmann-Vold","year":"2016","journal-title":"Chest"},{"issue":"11","key":"ref16","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1002\/art.38098","article-title":"2013 classification criteria for systemic sclerosis: an American College of Rheumatology\/European League against Rheumatism collaborative initiative","volume":"65","author":"F van den Hoogen","year":"2013","journal-title":"Arthritis Rheum"},{"issue":"2","key":"ref17","first-page":"202","article-title":"Scleroderma (systemic sclerosis): classification, subsets and pathogenesis","volume":"15","author":"E LeRoy","year":"1988","journal-title":"J Rheumatol"},{"issue":"3","key":"ref18","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1148\/radiol.2462070712","article-title":"Fleischner Society: glossary of terms for thoracic imaging","volume":"246","author":"D Hansell","year":"2008","journal-title":"Radiology"},{"issue":"11","key":"ref19","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1164\/rccm.200706-877OC","article-title":"Interstitial lung disease in systemic sclerosis: a simple staging system","volume":"177","author":"NS Goh","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"ref20","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1183\/09031936.00080312","article-title":"Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations","volume":"40","author":"PH Quanjer","year":"2012","journal-title":"Eur Respir J"},{"issue":"4","key":"ref21","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1183\/09031936.00155108","article-title":"Marginal decline in forced vital capacity is associated with a poor outcome in idiopathic pulmonary fibrosis","volume":"35","author":"CJ Zappala","year":"2010","journal-title":"Eur Respir J"},{"issue":"1","key":"ref22","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/eurheartj\/ehv317","article-title":"2015 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT)","volume":"37","author":"N Galie","year":"2016","journal-title":"Eur Heart J"},{"issue":"25 Suppl","key":"ref23","doi-asserted-by":"crossref","first-page":"D42","DOI":"10.1016\/j.jacc.2013.10.032","article-title":"Definitions and diagnosis of pulmonary hypertension","volume":"62","author":"MM Hoeper","year":"2013","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"ref24","doi-asserted-by":"crossref","first-page":"4692","DOI":"10.4049\/jimmunol.173.7.4692","article-title":"The Role of the Th2 CC Chemokine Ligand CCL17 in Pulmonary Fibrosis","volume":"173","author":"JA Belperio","year":"2004","journal-title":"The Journal of Immunology"},{"issue":"8","key":"ref25","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.healun.2012.04.008","article-title":"Type I immune response cytokine-chemokine cascade is associated with pulmonary arterial hypertension","volume":"31","author":"DJ Ross","year":"2012","journal-title":"J Heart Lung Transplant"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1755-1536-4-10","article-title":"Immune response CC chemokines CCL2 and CCL5 are associated with pulmonary sarcoidosis","volume":"4","author":"V Palchevskiy","year":"2011","journal-title":"Fibrogenesis Tissue Repair"},{"issue":"1","key":"ref27","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1136\/ard.2003.018705","article-title":"Up regulated expression of fractalkine\/CX3CL1 and CX3CR1 in patients with systemic sclerosis","volume":"64","author":"M Hasegawa","year":"2005","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"ref28","doi-asserted-by":"crossref","first-page":"435","DOI":"10.3899\/jrheum.120725","article-title":"Serum interleukin 6 is predictive of early functional decline and mortality in interstitial lung disease associated with systemic sclerosis","volume":"40","author":"A De Lauretis","year":"2013","journal-title":"J Rheumatol"},{"issue":"6","key":"ref29","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1016\/j.ajpath.2013.02.039","article-title":"Endothelial GATA-6 deficiency promotes pulmonary arterial hypertension","volume":"182","author":"A Ghatnekar","year":"2013","journal-title":"Am J Pathol"},{"issue":"4","key":"ref30","first-page":"527","article-title":"Increased serum fractalkine in systemic sclerosis. Down-regulation by prostaglandin E1","volume":"26","author":"J Sicinska","year":"2008","journal-title":"Clin Exp Rheumatol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0206545","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T08:57:51Z","timestamp":1589014671000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0206545"}},"subtitle":[],"editor":[{"given":"Masataka","family":"Kuwana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,11,20]]},"references-count":30,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2018,11,20]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0206545","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,20]]}}}